Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

Together, All of Our Actions Matter!

AIMHI_wpuser2025-02-21T16:00:08+00:00February 4, 2021|Press Release|

Oncoheroes Biosciences Secures Additional Venture Philanthropy Investment

AIMHI_wpuser2025-02-21T16:00:08+00:00January 19, 2021|Press Release|

SciTech Development Presenting at the 2021 China BioMed Forum during the 39th J.P. Morgan Healthcare Conference

AIMHI_wpuser2025-02-21T16:00:08+00:00December 30, 2020|Press Release|

AIM-HI Women’s Venture Competition Sponsor: Microsoft

AIMHI_wpuser2025-02-21T16:00:08+00:00December 15, 2020|Press Release|

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

AIMHI_wpuser2025-02-21T16:00:09+00:00November 20, 2020|Press Release|

Oncoheroes Biosciences’ Pediatric Cancer Drug Candidate Receives Orphan Drug Designation

AIMHI_wpuser2025-02-21T16:00:09+00:00October 14, 2020|Press Release|

Previous 789 Next

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2025 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2025 All Rights Reserved